KM Financial Solutions | Israeli medical cannabis firm InterCure plans Nasdaq listing
38940
post-template-default,single,single-post,postid-38940,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Israeli medical cannabis firm InterCure plans Nasdaq listing

Israeli medical cannabis firm InterCure plans Nasdaq listing

Israel’s InterCure,
which recently entered the medical cannabis market, plans to
list on Nasdaq by mid-2019, its controlling shareholder, Alex
Rabinovitch, said on Thursday.

No Comments

Sorry, the comment form is closed at this time.